The Expert Voice VL

From the Stage to the Clinic and Back: Medicine and Burnout - Stuart H. Bloom

Details
Stuart Bloom, MD, a well-known Twin Cities oncologist, joins Charles Ryan, MD to highlight his work on physician burnout including his theatrical play “How to Avoid Burnout in 73 Minutes”. The play represents Dr. Bloom's path to becoming a physician. Dr. Bloom spent the first 30 years of his life as an actor and comedian, the next 31 as a physician. In this conversation, the pair discuss how he co...

Lifestyle Interventions to Reduce Prostate Cancer Risk - Lorelei Mucci

Details
Lorelei Mucci joins Alicia Morgans in a conversation on exercise and nutrition in cancer care. Dr. Mucci provides an overview of the impact of lifestyle and nutrition on cancer and disease risk. She highlights specific types of dietary patterns that are associated with a lower risk of cancer overall, specifically more aggressive forms of prostate cancer or cancers that ultimately will become fatal...

Survivorship in Testicular Cancer - Mary Dunn

Details
The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...

The Impact of Unequivocal Clinical Progression on Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer - Arpit Rao

Details
Unequivocal clinical progression (UPC), a worsening of clinical status with or without radiographic progression represents a distinct mode of disease progression in metastatic prostate cancer. It is prognostic and associated with inferior overall survival and post-progression survival. In this conversation with Alicia Morgans, MD, MPH, Arpit Rao, MD highlights rigorous data set from the phase III...

Real World Evidence in the Treatment of mCRPC - Celestia Higano

Details
Real-world data on the use, survival impacts and efficacy of life-prolonging therapies for metastatic castration-resistant prostate cancer (mCRPC) are limited. In this conversation with Alicia Morgans, MD, MPH, Celestia Higano, MD highlights the publication Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in...

Overcoming Misinformation in the Diagnosis and Treatment of Kidney Cancer for Patients and Caregivers - Dena Battle

Details
Dena Battle from KCCure, a kidney cancer patient advocacy organization, joins Jaime Landman and Monty Pal to dispel common myths regarding the diagnosis and treatment of kidney cancer being observed in patient communities and to speak about what is driving this misinformation. Among the factors are evolving data, practice-changing data since first diagnoses, the lack of consensus where there isn’t...

Transformations in the Treatments of Prostate Cancer - A Look at 2020 - Charles Ryan & Alicia Morgans

Details
Drs Alicia Morgans and Charles Ryan review advancements in the treatment in prostate cancer from 2020. Dr. Ryan first reviews the Phase 3 HERO study, Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (ClinicalTrials.gov Identifier: NCT03085095), comparing relugolix, an oral gonadotropin-releasing hormone antagonist, to leuprolide in a 2:1 randomization which led to a very...

Disparities in Access to Quality Care for the Underinsured Patients in the USA - Quoc-Dien Trinh

Details
Underinsured patients face significant barriers in accessing high‐quality care. “Access Denied: The Relationship Between Patient Insurance Status and Access to High‐volume Hospitals” studies the evidence of whether access to high‐volume surgical care is mediated by disparities in health insurance coverage. Quoc-Dien Trinh, an author of the study, joins Alicia Morgans to discuss his involvement in...

No Dress Rehearsal: Treatment of Urethral Carcinoma - Curtis A. Pettaway

Details
Management decisions at presentation are critical for survival— a talk by Curtis A Pettaway, MD. Although primary urethral carcinoma (UC) is rare, with an incidence of 4.3 per million in men and 1.5 per million in women, recurrence is associated with distant metastases. Therefore, physicians will want to be alert to the possibility of UC when, for example, the patient has a urethral protrusion. Th...

Racial Differences in Genomic Profiling in Prostate Cancer - Brandon Mahal

Details
Studies have historically underrepresented Black and non-White prostate cancer patients limiting our understanding of the disparities in the diagnosis and prognosis of prostate cancer among these populations. Brandon Mahal, MD, joins Charles Ryan, MD, to discuss what he reported in this New England Journal of Medicine paper titled "Racial Differences in Genomic Profiling of Prostate Cancer." Biogr...
email news signup